Biocryst Pharmaceuticals (BCRX) Share-based Compensation Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.12 Bn | 214.41 Mn | -31.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.04% |
| Mar 31, 2026 | 1,086.31% |
| Dec 31, 2025 | 671.50% |
| Sep 30, 2025 | 363.95% |
| Jun 30, 2025 | -96.46% |
| Mar 31, 2025 | -42.51% |
| Dec 31, 2024 | -94.45% |
| Dec 31, 2023 | 289.04% |
| Dec 31, 2022 | -12.54% |
| Sep 30, 2022 | -83.53% |
| Jun 30, 2022 | -83.57% |
| Mar 31, 2022 | 75.23% |
| Dec 31, 2021 | -544.03% |
| Sep 30, 2021 | 176.09% |
| Jun 30, 2021 | 1,731.31% |
| Mar 31, 2021 | 98.95% |
| Dec 31, 2020 | 59.63% |
| Sep 30, 2020 | -14.86% |
| Jun 30, 2020 | -88.77% |
| Mar 31, 2020 | -16.97% |